4.2 Article

Comparison of potential risk factors for medication errors with and without patient harm

期刊

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
卷 19, 期 8, 页码 825-833

出版社

WILEY
DOI: 10.1002/pds.1977

关键词

medication errors; preventable adverse drug events; medication safety; hospitalised patients; determinants; pharmacocpidemiology

资金

  1. Netherlands Organization for Health Research and Development (ZonMw)

向作者/读者索取更多资源

Purpose To compare determinants for medication errors leading to patient harm with determinants for medication errors without patient harm. Methods A two-way case-control design was used to identify determinants for medication errors without harm (substudy I) and determinants for medication errors causing harm (substudy 2). Data of patients admitted to five internal medicine wards of two Dutch hospitals during 5 months were collected prospectively by chart review. Medication errors were detected and classified by two pharmacists. Consensus between five pharmacists was reached on the causal relationship between medication errors and patient harm. Data analysis was performed by multivariate logistic regression. Results We included 7286 medication orders, of which 3315 without errors (controls), and 5622 medication errors without harm (cases substudy 1) and 102 medication errors causing harm (cases substudy 2) were identified. Hospital, ward and the therapeutic class antiinfectives were associated with both medication errors without harm (hospital odds ratio (OR) 1.40; 95% confidence interval (CI) 1.21-1.63), TweeSteden hospital (TSh) geriatrics OR 2.03; 95% CI 1.73-2.38, TSh general internal medicine OR 1.44; 95% CI 1.23-1.69 and antiinfectivcs OR 1.28; 95% CI 1.06-1.56) and medication errors with harm (hospital OR 4.91; 95% CI 3.02-7.79, TSh geriatrics OR 5.76; 95% CI 2.52-13.15, TSh general internal medicine OR 6.51; 95% CI 2.82-15.02 and anti-infectives OR 4.20; 95% CI 2.24-7.90). Conclusions This study shows that organisational determinants (hospital, ward) are comparable for medication errors with and without harm. For conclusions on patient- and medication-related determinants studies with larger sample Sizes are needed. Copyright (C) 2010 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据